AMGEN INC Accounts Receivable 2008-2026 | AMGN
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is AMGEN INC's current accounts receivable?
AMGEN INC (AMGN) annual accounts receivable for 2025 was $9.57B, a 41.11% increase from 2024. AMGEN INC accounts receivable for the quarter ending March 31, 2026 was $9.14B.
What was AMGEN INC's accounts receivable in 2024?
AMGEN INC annual accounts receivable for 2024 was $6.78B, a 6.69% decline from 2023.
What was AMGEN INC's accounts receivable in 2023?
AMGEN INC annual accounts receivable for 2023 was $7.27B, a 30.65% increase from 2022.
What is AMGEN INC's 5-year accounts receivable CAGR?
AMGEN INC accounts receivable grew at a compound annual growth rate (CAGR) of 16.16% from FY2020 to FY2025, going from $4.53B to $9.57B over 5 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+16.2%
FY2020
$4.53B
→
FY2025
$9.57B
080910111213141516171819202122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.57B | +41.1% | 10-K |
| FY2024 | $6.78B | -6.7% | 10-K |
| FY2023 | $7.27B | +30.6% | 10-K |
| FY2022 | $5.56B | +13.6% | 10-K |
| FY2021 | $4.89B | +8.2% | 10-K |
| FY2020 | $4.53B | +11.5% | 10-K |
| FY2019 | $4.06B | +13.3% | 10-K |
| FY2018 | $3.58B | +10.6% | 10-K |
| FY2017 | $3.24B | +2.3% | 10-K |
| FY2016 | $3.17B | +5.7% | 10-K |
| FY2015 | $3.00B | +17.6% | 10-K |
| FY2014 | $2.55B | -5.6% | 10-K |
| FY2013 | $2.70B | +7.1% | 10-K |
| FY2012 | $2.52B | -13.1% | 10-K |
| FY2011 | $2.90B | +24.0% | 10-K |
| FY2010 | $2.33B | +10.7% | 10-K |
| FY2009 | $2.11B | +1.7% | 10-K |
| FY2008 | $2.07B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →